Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, placebo-controlled trial in 176 Korean subjects
Research output: Contribution to journal › Article › peer-review
34Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, placebo-controlled trial in 176 Korean subjects'. Together they form a unique fingerprint.